Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque Monkeys

Biological Psychiatry

Volumn 63, Issue 8, 2008, Pages 759-765

  Konopaske, Glenn T ^a,c,d   Dorph Petersen, Karl Anton ^a,e   Sweet, Robert A ^a   Pierri, Joseph N ^a   Zhang, Wei ^b   Sampson, Allan R ^b   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MCLEAN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Astrocyte; haloperidol; macaque monkeys; olanzapine; oligodendrocyte; stereology

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CONTROLLED STUDY; DRUG EXPOSURE; GRAY MATTER; IMMUNOCYTOCHEMISTRY; MACACA; MALE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PARIETAL LOBE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; ASTROCYTES; BENZODIAZEPINES; CELL COUNT; HALOPERIDOL; MACACA FASCICULARIS; MALE; OLIGODENDROGLIA; PARIETAL LOBE;

EID: 40849103017     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.08.018     Document Type: Article

References (47)

1. Elvevåg B., and Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14 (2000) 1-21
2. Atkins C.M., Chen S.J., Klann E., and Sweatt J.D. Increased phosphorylation of myelin basic protein during hippocampal long-term potentiation. J Neurochem 68 (1997) 1960-1967
3. Comi G., Filippi M., Martinelli V., Sirabian G., Visciani A., Campi A., et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis. J Neurol Sci 115 suppl (1993) S66-S73
4. Flynn S.W., Lang D.J., Mackay A.L., Goghari V., Vavasour I.M., Whittall K.P., et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8 (2003) 811-820
5. Hof P.R., Haroutunian V., Friedrich Jr. V.L., Byne W., Buitron C., Perl D.P., et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53 (2003) 1075-1085
6. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 4746-4751
7. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003) 798-805
8. Yang Y.F., Qin W., Shugart Y.Y., He G., Liu X.M., Zhou J., et al. Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr Res 75 (2005) 11-19
9. Konopaske G.T., Dorph-Petersen K.A., Pierri J.N., Wu Q., Sampson A.R., and Lewis D.A. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacol 32 (2007) 1216-1223
10. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., and Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacol 30 (2005) 1649-1661
11. Vogel U.S., Reynolds R., Thompson R.J., and Wilkin G.P. Expression of the 2',3'-cyclic nucleotide 3'-phosphohydrolase gene and immunoreactive protein in oligodendrocytes as revealed by in situ hybridization and immunofluorescence. Glia 1 (1988) 184-190
12. Rickmann M., and Wolff J.R. S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain. Neurosci Lett 186 (1995) 13-16
13. Oosthuizen P., Emsley R., Jadri Turner H., and Keyter N. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. Int J Neuropsychopharmacol 7 (2004) 125-131
14. Perry P.J., Lund B.C., Sanger T., and Beasley C. Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial. J Clin Psychopharmacol 21 (2001) 14-20
15. Baddeley A., Dorph-Petersen K.A., and Vedel Jensen E.B. A note on the stereological implications of irregular spacing of sections. J Microsc 222 (2006) 177-181
16. Peters S.R. The art of embedding tissue for frozen section. Part I: A system for face down cryoembedding of tissues using freezing temperature embedding wells. J Histotechnol 26 (2003) 11-19
17. Peters S.R. The art of embedding tissue for frozen section. Part II: Frozen block cryoembedding. J Histotechnol 26 (2003) 23-28
18. Windrem M.S., Roy N.S., Wang J., Nunes M., Benraiss A., Goodman R., et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 69 (2002) 966-975
19. McFerran B., and Burgoyne R. 2',3'-cyclic nucleotide 3'-phosphodiesterase is associated with mitochondria in diverse adrenal cell types. J Cell Sci 110 (1997) 2979-2985
20. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33 (2003) 366-374
21. Kofler B., Bulleyment A., Humphries A., and Carter D.A. Id-1 expression defines a subset of vimentin/S-100beta-positive, GFAP-negative astrocytes in the adult rat pineal gland. Histochem J 34 (2002) 167-171
22. Yu W.H., and Fraser P.E. S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J Neurosci 21 (2001) 2240-2246
23. Nishiyama H., Takemura M., Takeda T., and Itohara S. Normal development of serotonergic neurons in mice lacking S100B. Neurosci Lett 321 (2002) 49-52
24. Gundersen H.J.G. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones in the memory of William R. Thompson. J Microsc 143 (1986) 3-45
25. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: The edge effect. J Microsc 111 (1977) 219-223
26. Dorph-Petersen K.A. Neuronal Changes in the Dorsal Raphe Nucleus in Depression (2001), Doctoral Thesis University of Aarhus, Denmark
27. Dorph-Petersen K.A., Rosenberg R., and Nyengaard J.R. Estimation of number and volume of immunohistochemically stained neurons in complex brain regions. In: Evans S.M., Janson A.M., and Nyengaard J.R. (Eds). Quantitative Methods in Neuroscience (2004), Oxford University Press, Oxford 16-238
28. West M.J., Slomianka L., and Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231 (1991) 482-497
29. Gundersen H.J.G., and Østerby R. Optimizing sampling efficiency of stereological studies in biology: Or 'do more less well!'. J Microsc 121 (1981) 65-73
30. Gundersen H.J.G., Jensen E.B.V., Kiêu K., and Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J Microsc 193 (1999) 199-211
31. Dorph-Petersen K.A., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types. J Comp Neurol 472 (2004) 449-462
32. Sweet R.A., Dorph-Petersen K.A., and Lewis D.A. Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus. J Comp Neurol 491 (2005) 270-289
33. Zhang W., and Bymaster F.P. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology 141 (1999) 267-278 (Berl)
34. Konopaske G.T., Dorph-Petersen K.A., and Lewis D.A. Effect of chronic exposure to antipsychotic medications on glial cell numbers in the parietal cortex of macaque monkeys, Poster Presentation (2006), Society for Neuroscience Annual Meeting, Atlanta, Georgia
35. Hertz L. Intercellular metabolic compartmentation in the brain: Past, present and future. Neurochem Int 45 (2004) 285-296
36. Coyle J.T. The GABA-glutamate connection in schizophrenia: Which is the proximate cause?. Biochem Pharmacol 68 (2004) 1507-1514
37. Lewis D.A., and Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med 12 (2006) 1016-1022
38. Bak L.K., Schousboe A., and Waagepetersen H.S. The glutamate/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98 (2006) 641-653
39. Schousboe A., Sarup A., Bak L.K., Waagepetersen H.S., and Larsson O.M. Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem Int 45 (2004) 521-527
40. Chaudhry F.A., Lehre K.P., van Lookeren Campagne M., Ottersen O.P., Danbolt N.C., and Storm-Mathisen J. Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15 (1995) 711-720
41. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., et al. Localization of neuronal and glial glutamate transporters. Neuron 13 (1994) 713-725
42. Norenberg M.D., and Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161 (1979) 303-310
43. Bröer S., and Brookes N. Transfer of glutamine between astrocytes and neurons. J Neurochem 77 (2001) 705-719
44. Théberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 159 (2002) 1944-1946
45. Théberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., Rajakumar N., et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 160 (2003) 2231-2233
46. Dorph-Petersen K.A., Nyengaard J.R., and Gundersen H.J.G. Tissue shrinkage and unbiased stereological estimation of particle number and size. J Microsc 204 (2001) 232-246
47. Peterson D.A. The use of fluorescent probes in cell-counting procedures. In: Evans S.M., Janson A.M., and Nyengaard J.R. (Eds). Quantitative Methods in Neuroscience (2004), Oxford University Press, Oxford 86-114